Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 08 08 2018
accepted: 24 12 2018
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 16 4 2019
Statut: epublish

Résumé

Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal malaria chemoprevention (SMC) with amodiaquine and sulfadoxine-pyrimethamine provides substantial benefit to this vulnerable population, but resistance to the drugs will develop. Here, we evaluate the use of dihydroartemisinin-piperaquine as an alternative regimen in 179 children (aged 2.33-58.1 months). Allometrically scaled body weight on pharmacokinetic parameters of piperaquine result in lower drug exposures in small children after a standard mg per kg dosage. A covariate-free sigmoidal E

Identifiants

pubmed: 30696903
doi: 10.1038/s41467-019-08297-9
pii: 10.1038/s41467-019-08297-9
pmc: PMC6351525
doi:

Substances chimiques

Antimalarials 0
Artemisinins 0
Quinolines 0
artenimol 6A9O50735X
piperaquine A0HV2Q956Y

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

480

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K012126/1
Pays : United Kingdom

Références

Antimicrob Agents Chemother. 2007 Nov;51(11):4090-7
pubmed: 17846129
J Infect Dis. 2005 Feb 15;191(4):619-26
pubmed: 15655787
Clin Drug Investig. 2015 Sep;35(9):559-67
pubmed: 26293519
PLoS One. 2009 Sep 28;4(9):e7164
pubmed: 19784374
Clin Infect Dis. 2014 May;58(10):1404-12
pubmed: 24621953
Xenobiotica. 2012 Nov;42(11):1088-95
pubmed: 22671777
Antimicrob Agents Chemother. 2011 Sep;55(9):3971-6
pubmed: 21709087
PLoS Med. 2014 Aug 05;11(8):e1001689
pubmed: 25093754
Br J Clin Pharmacol. 2004 Mar;57(3):253-62
pubmed: 14998421
Trends Parasitol. 2002 Oct;18(10):458-64
pubmed: 12377597
Antimicrob Agents Chemother. 2015;59(6):3018-30
pubmed: 25753626
Sci Transl Med. 2014 Oct 29;6(260):260ra147
pubmed: 25355697
Malar J. 2012 Nov 29;11:398
pubmed: 23190801
J Pharmacokinet Pharmacodyn. 2002 Dec;29(5-6):473-505
pubmed: 12795242
PLoS Med. 2013 Dec;10(12):e1001564; discussion e1001564
pubmed: 24311989
Antimicrob Agents Chemother. 2003 Apr;47(4):1391-4
pubmed: 12654675
Am J Trop Med Hyg. 2010 Oct;83(4):873-5
pubmed: 20889882
Antimicrob Agents Chemother. 2014;58(4):2052-8
pubmed: 24449770
Eur J Clin Pharmacol. 2010 Jul;66(7):705-12
pubmed: 20300743
PLoS One. 2010 Jun 21;5(6):e11225
pubmed: 20574538
Antimicrob Agents Chemother. 2005 Jun;49(6):2407-11
pubmed: 15917540
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242661
Malar J. 2015 Sep 24;14:368
pubmed: 26403465
Malar J. 2017 Feb 23;16(1):88
pubmed: 28231817
Infect Immun. 2008 Feb;76(2):759-66
pubmed: 18070896
Antimicrob Agents Chemother. 2015 Aug;59(8):4387-96
pubmed: 25918149
Antimicrob Agents Chemother. 2014 Jul;58(7):3889-94
pubmed: 24777099
Comput Methods Programs Biomed. 2011 Jan;101(1):72-9
pubmed: 20627442
AAPS J. 2011 Jun;13(2):143-51
pubmed: 21302010
Clin Infect Dis. 2002 Dec 15;35(12):1469-76
pubmed: 12471565
Antimicrob Agents Chemother. 2012 Apr;56(4):1997-2007
pubmed: 22252822
CPT Pharmacometrics Syst Pharmacol. 2014 Aug 27;3:e132
pubmed: 25163024
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28923866
Antimicrob Agents Chemother. 1997 Jul;41(7):1413-22
pubmed: 9210658
Drug Metab Dispos. 2006 Dec;34(12):2011-9
pubmed: 16956956
Parasitology. 2002 Mar;124(Pt 3):247-63
pubmed: 11922427
PLoS One. 2009 Jul 29;4(7):e6358
pubmed: 19649267
Antimicrob Agents Chemother. 2012 Mar;56(3):1571-7
pubmed: 22252804
Antimicrob Agents Chemother. 2010 May;54(5):1949-54
pubmed: 20231394
Antimicrob Agents Chemother. 2008 Jan;52(1):237-43
pubmed: 17967917
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 1;862(1-2):227-36
pubmed: 18191623
Drug Metab Pharmacokinet. 2009;24(1):25-36
pubmed: 19252334
J Clin Pharmacol. 2008 Feb;48(2):166-75
pubmed: 18199893
Antimicrob Agents Chemother. 2014 Oct;58(10):5784-94
pubmed: 25049242
Expert Rev Anti Infect Ther. 2010 May;8(5):589-606
pubmed: 20455687
Clin Pharmacol Ther. 2012 Mar;91(3):497-505
pubmed: 22258469
Comput Methods Programs Biomed. 2004 Aug;75(2):85-94
pubmed: 15212851
PLoS One. 2013;8(1):e50036
pubmed: 23320064

Auteurs

Palang Chotsiri (P)

Faculty of Tropical Medicine, Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, 10400, Thailand.

Issaka Zongo (I)

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.

Paul Milligan (P)

Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom.

Yves Daniel Compaore (YD)

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.

Anyirékun Fabrice Somé (AF)

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.

Daniel Chandramohan (D)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom.

Warunee Hanpithakpong (W)

Faculty of Tropical Medicine, Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, 10400, Thailand.

François Nosten (F)

Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, London, OX3 7LJ, United Kingdom.
Faculty of Tropical Medicine, Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Sot, 63110, Thailand.

Brian Greenwood (B)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom.

Philip J Rosenthal (PJ)

Department of Medicine, University of California, Box 0811, San Francisco, CA 94143, CA, USA.

Nicholas J White (NJ)

Faculty of Tropical Medicine, Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, 10400, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, London, OX3 7LJ, United Kingdom.

Jean-Bosco Ouédraogo (JB)

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.

Joel Tarning (J)

Faculty of Tropical Medicine, Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, 10400, Thailand. joel@tropmedres.ac.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, London, OX3 7LJ, United Kingdom. joel@tropmedres.ac.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH